Home - NAPPSA Conferences

September 26-29th, 2024 in San Antonio Texas

MILESTONE MOMENTUM POST-PANDEMIC

The 18th Annual NAPPSA Scientific Conference & Exhibition

The 18th Annual NAPPSA Scientific Conference & Exhibition | 2024

On behalf of the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA), it is our pleasure to invite you to participate in our 18th Annual Scientific NAPPSA Conference and Exposition taking place at the Marriot San Antonio Airport, 77 NE Interstate 410 Loop, San Antonio, TX from September 26- 29, 2024.

Conference Starts in:

TARGET AUDIENCE

This program is designed for pharmacists, physicians, pharmaceutical scientists, and others interested in learning about the most current advances in pharmacy practice, pharmacy ownership, pharmaceutical education, drug discovery, development, regulation and the safe utilization of drugs.

CONTINUING EDUCATION CREDIT

This continuing education program is sponsored by the National Pharmaceutical Association which is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.

REFUND/ CANCELLATION/ SUBSTITUTION POLICY

Refunds for the 2024 NAPPSA Annual Meeting are honored only if written request is received by July 22, 2024. For “full registration” cancellations there will be a $75 administrative fee. No refunds will be honored after July 22, 2024. Alternatively, your registration cannot be transferred to the next year conference.

PHOTO RELEASE

Registrants of the NAPPSA Annual Meeting agree to allow NAPPSA and its official photographer and/or videographer to photograph or videotape them in the context of the Annual Meeting setting. Footage captured by the official NAPPSA photographer/videographer may be used in future print and electronic promotional and archival materials. More conference details to follow.

Conference Schedule

10:00 am - 5:00 pmLa Cantera Foyer

Registration

Registration

12:30 pm - 5:00 pmLa Cantera Ballroom

Session #100: Focused Milestones in the Sciences and Practice of Pharmacy

12:30 pm - 12:40 pmLa Cantera Ballroom

Emmanuel Ezirim, RPh, FNAPPSA

President, Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc., USA

Welcome Address

12:40 pm - 2:40 pmLa Cantera Ballroom

Session #100 (Part One)

Session #100 (Part One): Universal Activity Number: 0092-0000-24-400-L01-P (0.20 CEUs) Application-Based Activity. Moderators: Adeleye Ogunkanmi, PharmD, Director, Clinical Research, Genmab Inc, Princeton, NJ, USA, and Theresa Ofili, PharmD, Instructional Assistant Professor of Pharmacy Practice, Texas A&M School of Pharmacy, College Station, TX, USA

12:40 pm – 1:20 pmLa Cantera Ballroom

Janet Akande-Dokun, PhD

Cofounder, Moremme, Birmingham, AL, USA

#101: Innovation under pressure: Leveraging the non-obvious.

#101 Innovation Under Pressure Leveraging the Non-Obvious

1:20 pm – 2:00 pmLa Cantera Ballroom

Raghu Yendapally, BPharm, PhD, MBA,

Professor, University of the Incarnate Word, Feik School of Pharmacy, San Antonio, Texas, USA

#102: Advances in Antidiabetic Pharmacotherapy: Focus on SGLT2-Inhibitors.

#102 Advances in Antidiabetic Pharmacotherapy Focus on SGLT2-Inhibitors

2:00 pm – 2:40 pmLa Cantera Ballroom

Simon Agwale, PhD

Chief Executive Officer, Innovative Biotech Inc., Aberdeen, MD, USA

#103: Prospects in Vaccine Development for Prevention of Infectious Diseases and Treatment of Cancers

#103 Prospects in Vaccine Development for Prevention of Infectious Diseases and Treatment of Cancers

2:40 pm – 2:55 pmLa Cantera Foyer

Break

2:55 pm – 5:00 pmLa Cantera Foyer

Session #100 (Part Two)

Session #100 (Part Two): Universal Activity Number: 0092-0000-24-401-L01-P (0.20 CEUs) Application-Based Activity.

2:55 pm – 3:35 pmLa Cantera Ballroom

Nonye Onyewuenyi, PhD

Chief Executive Officer and CSO, NONIKS ANALYTICS & Consulting LLC. Lawrenceville, NJ, USA.

#104: Vaccine Process Development: Challenges and Opportunities from Project Management Perspective.

#104 Vaccine Process Development Challenges and Opportunities from Project Management Perspective

3:35 pm – 4:15 pmLa Cantera Ballroom

Josie Jacobs, PharmD, BCPS

Clinical Pharmacist, Department of Pharmacotherapy and Pharmacy Services, University Health System, San Antonio, TX, USA.

#105: Newer Pharmacological Treatments in Adults with Epilepsy: Cost-Effectiveness and Comorbidity Considerations

#105 Newer Pharmacological Treatments in Adults with Epilepsy Cost-Effectiveness and Comorbidity Considerations

4:15 pm – 5:00 pmLa Cantera Foyer

Q&A – Session Presenters and Moderators

6:00 pm

Welcome Reception & Networking

7:00 am - 5:00 pmLa Cantera Foyer

Registration

7:00 am - 8:30 amLa Cantera Foyer

Breakfast

8:30 am – 9:00 amLa Cantera Ballroom

Emmanuel Ezirim, RPh, FNAPPSA,

President, Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc., Columbus, OH, USA

Opening Ceremonies

9:00 am – 12:00 pmLa Cantera Ballroom

Session #200: Global Pharmaceutical Momentum Post-Pandemic: Milestones, Challenges and Opportunities

Universal Activity Number: 0092-0000-24-403-L04-P (0.30 CEUs) Application-Based Activity

9:00 am – 9:40 amLa Cantera Ballroom

Patrick Lukulay, PhD

President, Technology Solutions for Global Health, Washington, DC, USA

#201: Artificial Intelligence: Strategic Applications in Pharmaceutical Industry and supply chain.

9:40 am – 10:20 amLa Cantera Ballroom

Mazi Sam Ohuabunwa

Managing Consultant/CEO, Star Team Consult, Lagos, Nigeria

#202: Building from the Ashes of the Pandemic: Sustaining Momentum towards Pharmaceutical Innovation in Africa.

#202 Building from the Ashes of the Pandemic Sustaining Momentum towards Pharmaceutical Innovation in Africa

10:10 am – 10:50 amLa Cantera Ballroom

Anthony C Ikeme, PhD

Managing Partner, PharmaMedics Inc., West Chester, PA, USA

#203: Non-Profits and the Global Pharmaceutical Agenda: The Next Frontier in NAPPSA’s Milestone Momentum.

#203 Non-Profits and the Global Pharmaceutical Agenda The Next Frontier in NAPPSA’s Milestone Momentum

11:20 am – 12:00 pmLa Cantera Ballroom

Moderated Roundtable Discussion: Sustaining Global Pharmaceutical Momentum Post-Pandemic: Integrating Local efforts with the global vision

Moderated Roundtable Discussion: Sustaining Global Pharmaceutical Momentum Post-Pandemic: Integrating Local efforts with the global vision All Speakers Simon Agwale, PhD, CEO, Innovative Biotech USA Inc., Aberdeen, MD, USA. Barry Bleidt, PhD, PharmD, RPh, Florida A&M University, Tallahassee, FL, USA. Godwin Maduka, MD , Proprietor, Transatlantic University of Medicine and Health Sciences, Umuchukwu, Anambra State, Nigeria. Mazi Sam Ohuabunwa, Managing Consultant/CEO, StarTeam Consult, Lagos, Nigeria Moderator: Anthony C Ikeme, PhD, Managing Partner, PharmaMedics Inc., West Chester, PA, USA and Emmanuel Ezirim, RPh, FNAPPSA, President, Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc., Columbus, OH, USA.

10:50 am – 11:20 amLa Cantera Ballroom

Charles Esimone, PhD

Former Vice Chancellor, Nnamdi Azikiwe, University, Awka, Anambra State, Nigeria and Vice Chancelor, Transatlantic University of Medicine and Health Sciences, Umuchukwu, Anambra State, Nigeria.

#204: Driving Pharmaceutical Innovation post-COVID: The Position of Research Institutions as Key Players.

#204 Driving Pharmaceutical Innovation post-COVID The Position of Research Institutions as Key Players

12:00 pm – 12:30 pmAlamo Heights Ballroom

Poster Flashtalks

Posters: Abstract J1. Formulation, physical and in vivo evaluation of sweet orange of oil-based anti-inflammatory creams (Citrus sinensis L.). John D.N. Ogbonna, Department of Pharmaceutics, University of Nigeria, Nsukka, Enugu State, Nigeria Abstract J2. Noninvasive delivery of influenza Nanovaccine using Dissolving Microneedles, Emmanuel Adediran, Vaccine Nanotechnology Laboratory, Center for Drug Delivery and Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA Abstract J3. Development and Evaluation of Vaginal Suppository Containing Lactiplantibacillus pentosus KCA1 for Treatment of Bacterial Vaginosis: Can Fourier Transform-Infrared (FT-IR) Spectroscopy be Used for Identification of Lactiplantibacillus pentosus KCA1? Ijeoma N. Ebenebe, Department of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria Abstract J4. Assessment of vaginal health before and after treatment with a vaginal suppository containing Lactiplantibacillus pentosus KCA1. Ijeoma N. Ebenebe, Department of Pharmaceutical micorbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria Moderator: Okezie Aruoma, PhD, DSc, Professor, California State University, Los Angeles, CA, USA

12:30 pm – 3:00 pmAlamo Heights Ballroom

Exhibition – Lunch – Poster Viewing

3:00 pm – 5:30 pmLa Cantera Ballroom

Session #300: From Bench to Bedside: Current Trends, Advances and Challenges in Gene Therapy

Universal Activity Number: 0092-0000-24-404-L04-P (0.25 CEUs) Application-Based Activity Moderators: Olu Aloba, PhD, Vice President, CMC Services, Premier Consulting, Morrisville, NC, USA, and Juliet Obi, PhD Candidate, University of Maryland, Baltimore School of Pharmacy, Baltimore, MD, USA

3:00 pm – 3:30 pmLa Cantera Ballroom

Ike Ogbaa, MD

Vice President & Global Head of Medical Affairs, bluebird bio, Somerville, MA, USA

#301: Gene Therapy Journey in Sickle Cell Disease.

3:40 pm – 4:10 pmLa Cantera Ballroom

Ifeanyi Egbuni ke-Chukwuma, PharmD, BCPS, BCACP

Director of Pharmacy Services, University of Maryland Medical Center, Baltimore, MD, USA

#302 The Pharmacist’s Role in Gene Therapy Management.

#302 The Pharmacist’s Role in Gene Therapy Management

4:10 pm – 4:30 pmLa Cantera Ballroom

Q&A Session Presenters and Moderators

La Cantera ABC

Session #350: Realizing Tangible Growth in Nigeria’s Industrial Pharma Sector

Universal Activity Number: 0092-0000-24-409-L04-P (0.10 CEUs) Application-Based Activity. Venue: La Cantera ABC Moderator: Kunle Tometi, PharmD, Total Pharmacy, Dallas, TX

4:30 pm – 5:15 pmLa Cantera ABC

Ken Onuegbu

Chairman, National Association of Industrial Pharmacists of Nigeria (NAIP), Lagos, Nigeria.

#351: The Nigeria Industrial Pharma Sector – Achieving Growth Through Strategic Alliances.

#351 The Nigeria Industrial Pharma Sector – Achieving Growth Through Strategic Alliances

5:15 pm – 5:30 pmLa Cantera Ballroom

Q&A – Session Presenters and Moderators

7:00 pmSan Antonio Firefighters Banquet Hall , San Antonio IH 10 W, San Antonio, TX

Welcome Reception & Networking

6:00 am – 9:00 am

NAPPSA 5K Run/Walk

7:00 am – 5:00 pmLa Cantera Foyer

Registration

9:00 am – 10:00 amLa Cantera Foyer

Breakfast

10:00 am – 12:00 pmLa Cantera Ballroom

PARALLEL SESSION A – Session #400: Pharmacy Business

Universal Activity Number: 0092-0000-24-405-L04-P (0.20 CEUs) Application -Based Activity.

10:00 am – 10:45 amLa Cantera Ballroom

Zach Brown

Director of IT, Quest Pharmaceuticals Inc., Murray, KY, USA.

#401: DSCSA Compliance for Pharmacies.

10:45 am – 11:30 amLa Cantera Ballroom

Gerald Muforo, BS, PharmD, MBA, RPh.

Pharmacy Manager, Clinical Trainer, Walmart Pharmacy, Tampa, FL, USA

#402: Clinical Services in Your Pharmacy: Income Opportunities for Pharmacies.

#402 Clinical Services in Your Pharmacy Income Opportunities for Pharmacies

11:30 am – 12:00 pmLa Cantera Ballroom

#403: B2B Moderated Discussion: GPOs: Benefits and Reasons to Join

All Speakers Nnodum Iheme, RPh, President, Ziks Pharmacy, Dayton, OH, USA Doug Towle, Vice President of Sales & Business Development, The Pharmacy Hub, Miami FL, USA Emeka Chinaka, PharmD, President, Chinakas Pharmacy, Moreno Valley, CA, USA Emmanuel Ayanjoke, PharmD, Owner, Altev Community Pharmacy, Cincinnati, OH, USA Moderator: Emmanuel Ezirim, RPh, FNAPPSA, President, Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc., USA.

10:00 am – 11:30 amAlamo Heights Ballroom

PARALLEL SESSION B – Session #500: Young Professionals Transferable Skills Workshop

Universal Activity Number: 0092-0000-24-406-L04-P (0.15 CEUs) Application -Based Activity.

10:00 am – 10:45 amAlamo Heights Ballroom

Barry Bleidt, PhD, PharmD, RPh

Adjunct Professor, Economic, Social & Administrative Pharmacy Division, FAMU, Tallahassee, FL, USA

#501: Transferable Skills: Motivational Interviewing and how it translates to better Communication and Teamwork.

#501 Transferable Skills Motivational Interviewing and how it translates to better Communication and Teamwork.

10:45 am – 11:30 amConference Room 3/4

Sheriff Benson, PharmD

Staff Pharmacist, CVS Health, Columbus, OH, USA

#502: Transferable Skills: Learning how to Use AI: A Beginners 101.

#502 Transferable Skills Learning how to Use AI A Beginners 101

12.00 pm - 2:00 pmAlamo Heights Ballroom

Exhibition – Lunch – Poster Viewing

2:00 pm – 4:00 pmLa Cantera Ballroom

Session #600: Pharmacy Practice Updates and Trends

Universal Activity Number: 0092-0000-24-406-L04-P (0.20 CEUs) Application-Based Activity. Moderator: Kunle Tometi, PharmD, Total Pharmacy, Dallas, TX

2:00 pm – 2:30 pmLa Cantera Ballroom

Jude Nwokike, PhD

Vice President, United States Pharmacopeia, North Bethesda, MD, USA.

#601: Access to New Medicines and Biologics in Africa – Workforce and Regulatory Challenges.

#601 Access to New Medicines and Biologics in Africa – Workforce and Regulatory Challenges

2:30 pm – 3:00 pmLa Cantera Ballroom

Jessica Njoku, PharmD

System Manager, Clinical Pharmacy Services - Harris Health System, Houston, TX, USA

#602: Continuous Glucose Monitoring Landscape and Integration with Insulin Systems.

#602 Continuous Glucose Monitoring Landscape and Integration with Insulin Systems

3:00 pm – 3:30 pmLa Cantera Ballroom

Nonye Iwuchukwu, PharmD

Oncology Clinical Pharmacist, Lester and Sue Smith Clinic, Houston, TX, USA

#603: Pathways to Board Certifications for Pharmacists.

#603 Pathways to Board Certifications for Pharmacist

3:30 pm – 4:00 pmLa Cantera Ballroom

Buddy King

Sales & Business Development, Dakoda Health

#604: Semaglutide Opportunities.

#604 Semaglutide Opportunities

4:00 pm – 4:15 pmLa Cantera Ballroom

Q&A All Session Presenters and Moderator

4:15 pm – 6:45 pmAlamo Heights Ballroom

NAPPSA 2024 Annual General Membership Meeting

8:00 pm - 12:00 amLa Cantera Ballroom

Conference Banquet

7:00 am – 11:00 amLa Cantera Foyer

Registration

8:30 am – 12:00 pmLa Cantera Ballroom

Session #700: Cardiovascular-Kidney-Metabolic (CKM) Syndrome, Part 1

Universal Activity Number: 0092-0000-24-407-L01-P (0.15 CEUs) Application-Based Activity

Moderators: Patrick Nwakama, PharmD, BCPS, Food and Drug Administration, Silver Springs, MD, USA, and Chidera Nwanna, PharmD, MBA, Walgreens, Midland, TX, USA.

8:30 am – 9:30 amLa Cantera Ballroom